News Archive

BPGbio, Inc. acquired substantially all of the assets of Berg, LLC, and licenses from Berg, LLC the use of the Berg and Berg Health names.
-
April 12, 2023 |
News and Updates, News Archive
Framingham biotech strikes DOD partnership as it marches toward IPO
read moreTwo months post-acquisition, BPGbio has signed a new, five-year partnership with the Department of Defense and laid out a near-term plan to get to the public markets.
-
September 15, 2021 |
Media, News Archive
Exclusive: Berg Health, Microsoft partner on cloud-based bioanalysis tool
read moreBy Rowan Walrath – Life Sciences Reporter, Boston Business Journal With just one partnership, Framingham bioanalytics firm Berg Health LLC is going from a small Massachusetts company to a global firm. At least, that’s how CEO and co-founder Niven Narain sees it. His company has just signed a first-ofits- kind partnership with Microsoft to integrate…
-
September 7, 2021 |
Media, News Archive
Biomarker panel to elevate prostate cancer diagnostics: Berg
read moreThe clinical-stage biotech firm and a number of high-profile partners have collaborated on biomarker technology to deliver a more accurate, less invasive option. Click here to view the full article at Outsourcing-Pharma.com.
-
April 1, 2021 |
Media, News Archive
Berg taps into supercomputer to battle COVID-19 variants
read moreThe advanced biotech analysis company is harnessing the power of a formidable supercomputer to discover potential treatments for the virus and mutations. Click here to view the full article at Outsourcing-Pharma.com.
-
October 6, 2020 |
Media, News Archive
Healthcare Leaders Pioneer A New Collaboration Model To Transform The Future Of Drug Development
read moreIn an October 6, 2020 Forbes.com column, Robert Reiss, Contributor Leadership Strategy moderated what he believes to be a key step in the pioneering of a new collaborative drug development model. The new series called, the BERG Healthcare Exchange, which will occur quarterly, will focus on key issues and trends impacting the future of healthcare…
-
September 29, 2020 |
Media, News Archive
Berg Fuels Study of African-American COVID-19 Patients
read moreResults from the research indicate use of ACE in inhibitors and ARBs could prove useful in treating COVID-19 patients of African-American descent. Click here to view the full article at Outsourcing-Pharma.com.